MAM
Razorfish India appoints Bharatesh Salian as VP & head of strategy
MUMBAI: Razorfish India has roped in Bharatesh Salian as its vice president and head of strategy. He will be based out of its Mumbai office.
“With a strong technology background and in-depth understanding of brands and consumer behaviour to boot, it is a unique combination that is not easy to come by,” said Razorfish India COO Gaurav Pathak.
He added, “His more than 14 years of rich experience in mobile, digital and social media domains will be valuable for us to strengthen Razorfish’s capabilities in business transformation.”
Prior to joining Razorfish, he was with VivaConnect as chief strategy officer where he worked with clients like BJP, GSK, Google and Tata Motors. In his tenure at TechShastra, he developed innovative solutions for Unilever, Pepsi, Nescafe, Zee TV and Network 18 amongst others.
A recipient of the ‘Innovative Leader Award’ at Indira International Innovation Summit, January 2013, Salian said, “Razorfish has always been known to be at the cutting edge of technology blending creativity, media and technology seamlessly. Its philosophy of world changing ideas and business transformation resonates with my own ambition of being at the forefront of India’s digital transformation.”
Razorfish India CEO Charulata Ravi Kumar informed, “We are constantly seeking out the most curious and innovative minds with fire in the bellies! And of course those who are not bound by the past but creating new tomorrows.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
